Modi Govt Revs Up Drive to Make Bulk Drugs in India, Forms New Panel to Push PLI

Indian drug-makers import more than 80 per cent of their total Active Pharmaceutical Ingredient (APIs) or bulk drug requirements from China. The scheme aims to increase the domestic product of these raw materials